{"id":"https://openalex.org/W64684524","doi":"https://doi.org/10.1007/978-94-011-3528-3_13","title":"D2 Dopamine Receptors and Schizophrenia","display_name":"D2 Dopamine Receptors and Schizophrenia","publication_year":1991,"publication_date":"1991-01-01","ids":{"openalex":"https://openalex.org/W64684524","doi":"https://doi.org/10.1007/978-94-011-3528-3_13","mag":"64684524"},"language":"en","primary_location":{"id":"doi:10.1007/978-94-011-3528-3_13","doi":"https://doi.org/10.1007/978-94-011-3528-3_13","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-94-011-3528-3_13","pdf_url":null,"source":{"id":"https://openalex.org/S4306463937","display_name":"Springer eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Brain Dopaminergic Systems: Imaging with Positron Tomography","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W2494591362","display_name":"Brain Dopaminergic Systems: Imaging with Positron Tomography"},"type":"book-chapter","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111752970","display_name":"J. L. Martinot","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"J. L. Martinot","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5111752970"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.05095541,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"169","last_page":"180"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.008999999612569809,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12308","display_name":"Mental Health and Psychiatry","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dopamine-d2-receptor","display_name":"dopamine D2 receptor","score":0.9459999799728394},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9950000047683716},{"id":"https://openalex.org/keywords/dopamine-hypothesis","display_name":"dopamine hypothesis","score":0.7870000004768372},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.7179999947547913},{"id":"https://openalex.org/keywords/antipsychotic-effects","display_name":"antipsychotic effects","score":0.7929999828338623},{"id":"https://openalex.org/keywords/dopamine-d2-receptor-occupancy","display_name":"dopamine D2 receptor occupancy","score":0.9070000052452087},{"id":"https://openalex.org/keywords/receptor-antagonism","display_name":"receptor antagonism","score":0.609000027179718},{"id":"https://openalex.org/keywords/positron-emission-tomography","display_name":"positron emission tomography","score":0.8709999918937683}],"concepts":[{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.7800251245498657},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.7147622108459473},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.6620278358459473},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5689472556114197},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.542800784111023},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.541588544845581},{"id":"https://openalex.org/C2775842073","wikidata":"https://www.wikidata.org/wiki/Q208376","display_name":"Positron emission tomography","level":2,"score":0.529875636100769},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.5097903609275818},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.507595419883728},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4939761757850647},{"id":"https://openalex.org/C120069818","wikidata":"https://www.wikidata.org/wiki/Q415496","display_name":"Dopamine receptor","level":3,"score":0.4918108284473419},{"id":"https://openalex.org/C3019878999","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic drug","level":4,"score":0.4116401672363281},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40431082248687744},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36246153712272644},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3596099019050598},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2279798686504364}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1007/978-94-011-3528-3_13","doi":"https://doi.org/10.1007/978-94-011-3528-3_13","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-94-011-3528-3_13","pdf_url":null,"source":{"id":"https://openalex.org/S4306463937","display_name":"Springer eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Brain Dopaminergic Systems: Imaging with Positron Tomography","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W287940607","https://openalex.org/W1606907902","https://openalex.org/W1976511025","https://openalex.org/W1985822892","https://openalex.org/W1991724312","https://openalex.org/W1997485587","https://openalex.org/W2001420036","https://openalex.org/W2003531628","https://openalex.org/W2009447429","https://openalex.org/W2016455950","https://openalex.org/W2021314674","https://openalex.org/W2025240330","https://openalex.org/W2037526139","https://openalex.org/W2050160168","https://openalex.org/W2065432160","https://openalex.org/W2069757353","https://openalex.org/W2070820559","https://openalex.org/W2078796499","https://openalex.org/W2087224269","https://openalex.org/W2114902684","https://openalex.org/W2141615636","https://openalex.org/W2144407004","https://openalex.org/W2159996636","https://openalex.org/W2162046522","https://openalex.org/W2406046152","https://openalex.org/W2936632311","https://openalex.org/W4301744530"],"related_works":["https://openalex.org/W2171175841","https://openalex.org/W2092820864","https://openalex.org/W148478230","https://openalex.org/W2025240330","https://openalex.org/W14947124","https://openalex.org/W36773419","https://openalex.org/W2162046522","https://openalex.org/W2519617027","https://openalex.org/W2022725791","https://openalex.org/W137372323"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-10T09:11:00.788812","created_date":"2016-06-24T00:00:00"}